Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00468741 · ClinicalTrials.gov registry record · NA
Component and Couple Analysis of Cancer Communications
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 338
- Enrollment target
NCT00468741: Completed NA study, sponsored by University of Wisconsin, Madison.
NCT00468741 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 338 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00468741, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 338 participants
- Enrollment target
Study Summary
Component and Couple Analysis of Cancer Communication CHESS, the Comprehensive Health Enhancement Support System is an innovative technology that provides information, social support and skills training to women with breast cancer. Previous CHESS clinical trials found improved patient outcomes but little is known about what services in CHESS produce those results. This study will examine whether breast cancer patient outcomes change when conceptually distinct CHESS services (information, social support, and skills training) are systematically added to a patients treatment resources. Primary Aims: * Determine the relative efficacies of different types of cancer communication treatments when they are presented alone or in combination * Determine routes or processes via which these elements work * Determine for whom the different treatment types work best.
Interventions
- BEHAVIORAL CHESS (Comprehensive Health Enhancement Support System)
- BEHAVIORAL CHESS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 338 participants |
| Start Date | 2003-09 |
| Est. Completion | 2014-06 |
| Phase | NA |
What the finished NCT00468741 record still lists
NCT00468741 is an interventional study that assigns participants to a tested intervention. The registered 338 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (76% lower).
The record links to 0 conditions, and to 2 interventions - of which CHESS (Comprehensive Health Enhancement Support System) is the first listed.
NCT00468741 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00468741 about?
NCT00468741 is a clinical study titled "Component and Couple Analysis of Cancer Communications". Component and Couple Analysis of Cancer Communication CHESS, the Comprehensive Health Enhancement Support System is an innovative technology that provides information, social support and skills training to women with breast cancer. Previous CHESS clinical trials found improved patient outcomes but ...
What is the current status of trial NCT00468741?
This trial is currently completed. It is a NA study. The enrollment target is 338 participants. The study started on 2003-09. Estimated completion is 2014-06.
What interventions are being tested in trial NCT00468741?
The interventions under investigation include: CHESS (Comprehensive Health Enhancement Support System) (BEHAVIORAL), CHESS (BEHAVIORAL).
Who is sponsoring clinical trial NCT00468741?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00468741's enrollment target sits among peer trials
338 305th of 2000 higher than 1,696 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03253263 · 338 participants · Phase 2
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
- NCT05658731 · 338 participants · NA
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- NCT06022939 · 338 participants · Phase 3
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia